Introduction

Selective brands. Quality you can trust.

MediSense established and started business by launching selective multinational brands in the Saudi market since 2011. The company has expanded into multiple healthcare categories — pharmaceuticals; food supplements, vitamins and dietary supplements; consumer and OTC products; specialty hair and skin care; and medical devices, consumables and disposables — building a curated portfolio that serves both private and public sectors across the Kingdom.

5 product categories

Our Vision

To become leaders in offering highly demanded products and services that serve a pool of elite customers with dedication and commitment to the highest quality standards — and to become one of the top 10 pharmaceutical companies in Saudi Arabia by the year 2030, while maintaining a steady and healthy growth in market share and diversification.

Our Mission

To become the best customer choice for unique skin care, pharmaceutical products, medical devices, and food supplements that serve to attract and maintain valuable and loyal customers — staying selective in offering the right products and services to the Saudi market.

Key Success Factors

Key Success Factors

Product Quality & Uniqueness

Selectivity is the heart of MediSense. Every brand we represent is chosen for its quality, uniqueness, and demonstrated value to patients and practitioners.

Operational Excellence

High management and operational quality ensures punctual delivery and tight cost control — through SFDA-approved warehouses, our own fleet, and disciplined logistics.

Expanded Nationwide Coverage

A highly motivated and experienced team reaches every major city and governorate in the Kingdom, serving private pharmacy chains, hospitals, and government tenders alike.

History & Timeline

History & Timeline

Our progress over time

2011

Beginning of communication with multiple brands like Skin Doctors, Pjur, and Rougj.

2013

New partners and products registered from Finland and Germany.

2015

Expansion into food supplements, OTC products, and medical devices.

2017

Achieving new records and broader portfolio reach.

2018

Expansion to a larger number of SKUs within the same brands.

2020

Client expansion and new deals with cosmetic suppliers.

2022

Continuous portfolio growth in urology, wound dressing, ICU, OTC and pharma.

2024

Launching first-to-market molecules and expanding in professional aesthetic products.

The Saudi Market

The Saudi Market

A region of growth and opportunity

$17B
Largest pharma & medical devices market with $17B annual revenue.
9%
Growing yearly at approximately 9% in the private market.
32%
Annual revenue growth rate for pharmacies is 32%.
#1
The largest economy in the Middle East.